Assignee
SYNTENY THERAPEUTICS INC
US·0 granted patents·5 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
5 records- 0169US2025320521A1Erythroparvovirus compositions and methods for gene therapySYNTENY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0269US2025302994A1Erythroparvovirus with a modified genome for gene therapySYNTENY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0369US2025295810A1Erythroparvovirus with a modified capsid for gene therapySYNTENY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0461US2025087304A1Genomic safe harborsSYNTENY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0559US2024066080A1Protoparvovirus and tetraparvovirus compositions and methods for gene therapySYNTENY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SYNTENY THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →